Back to Results
First PageMeta Content
Syndromes / Eye / Human physiology / Tears / Lacrimal gland / Hyaluronan / Benzalkonium chloride / Fluorescein / Keratoconjunctivitis sicca / Health / Chemistry / Anatomy


Report on the Deliberation Results March 5, 2010 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare
Add to Reading List

Document Date: 2014-03-10 21:30:29


Open Document

File Size: 454,87 KB

Share Result on Facebook

City

Bradford / /

Company

Diquafosol Sodium [Name of applicant] Santen Pharmaceutical Co. Ltd. / Yamasa Corporation / Diquafosol Sodium Santen Pharmaceutical Co. Ltd. / Inspire Pharmaceuticals Inc. / Santen Pharmaceutical Co. Ltd. / /

Country

Japan / United States / /

Currency

pence / /

IndustryTerm

drug solution / ophthalmic solution / pharmaceutical product / aqueous ophthalmic solution / drug product / biological product / degradation products / manufacturing process / specified biological product / /

MedicalCondition

chronic multifactorial disease / sterility / Stevens-Johnson syndrome / Sjogren’s syndrome / /

MedicalTreatment

pharmacotherapies / /

Organization

First Committee on New Drugs / Pharmaceuticals and Medical Devices Agency / Pharmaceutical Affairs Department of the Pharmaceutical Affairs / Pharmaceutical Affairs and Food Sanitation Council / Food Safety / Evaluation and Licensing Division / None Office / Ministry of Health / /

Product

Cl / IV This English / /

PublishedMedium

the Japanese review / /

Technology

hybridization / pharmacodynamics / /

SocialTag